Oxford Metrics plc (OMG)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 34.80 |
|---|---|
| 52-week range | 27.50 – 60.40 |
| Return, 1 month / 3 months | −5.4% / −11.0% |
| Return, 1 year / 3 years | −15.8% / −50.6% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 36.5% |
| Worst drawdown (1 year) | -41.8% |
| Average daily value traded | 16.38M GBX |
| Dividend yield | 9.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Oxford Metrics is a technology company based in Oxford in the United Kingdom. Through its Vicon business, it makes motion capture systems and computer vision software that record and analyse how people and objects move. Its customers include researchers and clinicians in life sciences, studios producing animation and visual effects for entertainment, and engineers working on product design and testing. The company supplies both the cameras and sensors and the software that turns the captured movement into usable data.
Oxford Metrics plc trades under the code OMG on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Oxford Metrics plc (OMG) trades on the London Exchange in UK. It last closed at GBX 34.80 on 23 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,764 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.8% and over the last three months it fell 11.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 15 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.9% | ||
| From 52-week high | -41.4% | ||
| Momentum | 22 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.0% | ||
| 6-month return | -28.0% | ||
| 12-month return, skipping the last month | -11.0% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.8% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 16.38M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 9.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +3.0% |
|---|---|
| 1 month | −5.4% |
| 3 months | −11.0% |
| 6 months | −28.0% |
| 1 year | −15.8% |
| 3 years | −50.6% |
| 5 years | −65.2% |
Signals
| 50-day / 200-day average | 37.01 / 44.01 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.81 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Feb 2026 | GBP 0.0325 |
| 12 Dec 2024 | GBP 0.0325 |
| 14 Dec 2023 | GBP 0.0275 |
| 29 Dec 2022 | GBP 0.0250 |
| 9 Dec 2021 | GBP 0.0200 |
| 10 Dec 2020 | GBP 0.0180 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.